Keywords: wellcome, stops, campath-1h, development, announced, decided, discontinue

Wellcome Stops Campath-1H Development

Article | 03 October 1994

Print This

Wellcome has announced that it has decided to discontinue studies of Campath-1H, a monoclonal antibody it licenses from British ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in